FROM NICHE, TO NORM.
GLP-1’s are replacing ‘going on a diet’ as the preferred weight loss quick fix.
Find out how this is presenting a huge opportunity for supplement choices to adapt their appeal along the GLP-1 user journey, as users focus on losing, and then maintaining their weight.
The GLP-1
User Lifecycle:
What to Expect
Our latest whitepaper draws on proprietary research from over 2,600 U.S. adults to explore how GLP-1 treatments are reshaping consumer behavior.
Examining the Before, During, and After,
this research helps the supplement industry navigate shifting demand, preferences, and eating habits in an evolving market.
BEFORE
Individuals turn to GLP-1 for different
reasons, from managing weight to
controlling diabetes.
77% seek weight loss and appetite control,
while 23% use it for diabetes management,
spanning all age groups.
Many have faced lifelong struggles
with weight, highlighting the diverse
motivations behind starting this treatment.
DURING
While GLP-1 medications appear to offer
significant benefits, many users face
gastrointestinal side effects.
Around ¼ users experience GI discomfort, with
35% reporting nausea, 24% experiencing
diarrhea, and 22% suffering from
constipation
Rapid weight loss can also lead to lean
muscle loss. Supporting gut health,
possibly with probiotics, may help
improve user experience.
AFTER
Maintaining weight loss after GLP-1
treatment is a growing concern. After
stopping weekly semaglutide (2.4 mg),
users regained two-thirds of lost
weight, with similar cardiometabolic
changes.
42% of consumers seek products to
sustain results. As obesity is now
recognized as a chronic disease, long-term
management solutions are
essential.